Calton & Associates, Inc. Novo Nordisk A S Transaction History

Calton & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $228,553 - $259,969	-5,502 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$46.76 - $51.24 $8,977 - $9,838	192 Added 3.62%	5,502 $259,000
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $235,179 - $267,730	5,310 New	5,310 $250,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.